Telo Genomics Corp
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive o… Read more
Market Cap & Net Worth: Telo Genomics Corp (TDSGF)
Telo Genomics Corp (OTCQB:TDSGF) has a market capitalization of $6.14 Million ($6.14 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #32238 globally and #10587 in its home market, demonstrating a 5.34% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Telo Genomics Corp's stock price $0.06 by its total outstanding shares 100430472 (100.43 Million).
Telo Genomics Corp Market Cap History: 2016 to 2025
Telo Genomics Corp's market capitalization history from 2016 to 2025. Data shows change from $328.26 Million to $6.14 Million (-37.06% CAGR).
Telo Genomics Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Telo Genomics Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TDSGF by Market Capitalization
Companies near Telo Genomics Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Telo Genomics Corp by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Telo Genomics Corp Historical Marketcap From 2016 to 2025
Between 2016 and today, Telo Genomics Corp's market cap moved from $328.26 Million to $ 6.14 Million, with a yearly change of -37.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.14 Million | -27.26% |
| 2024 | $8.44 Million | -40.00% |
| 2023 | $14.06 Million | -42.86% |
| 2022 | $24.61 Million | -23.20% |
| 2021 | $32.04 Million | +53.37% |
| 2020 | $20.89 Million | +63.78% |
| 2019 | $12.75 Million | +6.72% |
| 2018 | $11.95 Million | -88.82% |
| 2017 | $106.86 Million | -67.45% |
| 2016 | $328.26 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Telo Genomics Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.14 Million USD |
| MoneyControl | $6.14 Million USD |
| MarketWatch | $6.14 Million USD |
| marketcap.company | $6.14 Million USD |
| Reuters | $6.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.